(secondQuint)Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome.

 The purpose of this study is to evaluate the effects of EPI-743 in patient with Leigh syndrome on disease severity, neuromuscular function, respiratory function, disease morbidity and mortality and biomarkers associated with the disease.

 This study is a six month prospective randomized double-blind, placebo-controlled trial with a six month extension phase of two dose levels of EPI743.

 The planned enrollment is for approximately 30 children with genetically confirmed Leigh syndrome.

 After 6 months of treatment, those children that were randomized to the placebo treatment arm will be re-randomized to one of the 2 active treatment arms.

.

 Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome@highlight

The purpose of this study is to evaluate the effects of EPI-743 in children with Leigh syndrome on disease severity, neuromuscular function, respiratory function, disease morbidity and mortality and disease associated biomarkers.

